PATENT CLAIM ANALYSIS

Application Number: 16061369
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-02
Patent Classification: ["514", "081000"]

Abstract:
The present invention relates to spirocyclic quinolizine derivatives and pharmaceutically acceptable salts or prodrug thereof, compositions comprising at least one spirocyclic quinolizine derivative, and methods of using the spirocyclic quinolizine derivatives for treating or preventing HIV infection in a subject.

Claim (Index 17):
A compound of  claim 1 , or a pharmaceutically acceptable salt thereof, for use in the preparation of a medicament for the inhibition of HIV integrase, for the treatment or prophylaxis of infection by HIV, or for the treatment, prophylaxis, or delay in the onset or progression of AIDS in a subject in need thereof.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.22857
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15560896', '15775871', '15575433', '15775966', '14652580']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8099629465222871
- 35 USC 102 Novelty (BERT): 0.5772659239564878
- Combined Prediction Score: 0.7866932442657072
- Mean Citation Score: 442.889044
- Max Citation Score: 454.46243
- Similarity Product: 419.02288908519984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test